Paracrine utilizes an autologous mixed population of adipose-derived regenerative cells that contribute to multiple cell lineages and mechanisms of action to treat complex conditions. This unique heterogeneous cell therapy addresses critical underlying pathologic conditions. The company’s Celution System can process these regenerative cells in about an hour right at the bedside . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

The post On Point: Paracrine’s Cell Therapy Uses Adipose-Derived Regenerative Cells for Autologous Reimplantation appeared first on GEN – Genetic Engineering and Biotechnology News.